These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 33105750)

  • 21. Purinergic Receptors in Thrombosis and Inflammation.
    Hechler B; Gachet C
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
    Chiarella AM; Ryu YK; Manji GA; Rustgi AK
    Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purines and sensory nerves.
    Burnstock G
    Handb Exp Pharmacol; 2009; (194):333-92. PubMed ID: 19655112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.
    Schneider G; Glaser T; Lameu C; Abdelbaset-Ismail A; Sellers ZP; Moniuszko M; Ulrich H; Ratajczak MZ
    Mol Cancer; 2015 Nov; 14():201. PubMed ID: 26597723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors.
    Ryu JK; Kim J; Choi SH; Oh YJ; Lee YB; Kim SU; Jin BK
    Neuroreport; 2002 Sep; 13(13):1611-5. PubMed ID: 12352612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of ecto-purines in inflammation leading to demyelination - new means for therapies against multiple sclerosis].
    Cieślak M; Komoszyński M
    Neurol Neurochir Pol; 2011; 45(5):489-99. PubMed ID: 22127945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purinoceptors in the nervous system.
    Fredholm BB
    Pharmacol Toxicol; 1995 Apr; 76(4):228-39. PubMed ID: 7617551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of astrocytes in purine-mediated reparative processes in the brain.
    Ciccarelli R; Ballerini P; Sabatino G; Rathbone MP; D'Onofrio M; Caciagli F; Di Iorio P
    Int J Dev Neurosci; 2001 Jul; 19(4):395-414. PubMed ID: 11378300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smooth muscle and purinergic contraction of the human, rabbit, rat, and mouse testicular capsule.
    Banks FC; Knight GE; Calvert RC; Turmaine M; Thompson CS; Mikhailidis DP; Morgan RJ; Burnstock G
    Biol Reprod; 2006 Mar; 74(3):473-80. PubMed ID: 16280417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purinergic signalling and disorders of the central nervous system.
    Burnstock G
    Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cytokine-mediated JNK signalling by purinergic P2Y
    Ng PY; McIntosh KA; Hargrave G; Ho KH; Paul A; Plevin R
    Cell Signal; 2018 Nov; 51():59-71. PubMed ID: 30076967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purinergic and pyrimidinergic receptors as potential drug targets.
    Williams M; Jarvis MF
    Biochem Pharmacol; 2000 May; 59(10):1173-85. PubMed ID: 10736418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
    Neary JT; McCarthy M; Kang Y; Zuniga S
    Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials.
    da Silva Ferreira NC; Alves LA; Soares-Bezerra RJ
    Curr Drug Targets; 2019; 20(9):919-937. PubMed ID: 30760187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the purinergic signaling in epilepsy.
    Cieślak M; Wojtczak A; Komoszyński M
    Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy.
    Wong ZW; Engel T
    Neuropharmacology; 2023 Jan; 222():109303. PubMed ID: 36309046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P1-/P2-purinergic receptors on cultured rabbit retinal Müller cells.
    Liu Y; Wakakura M
    Jpn J Ophthalmol; 1998; 42(1):33-40. PubMed ID: 9507363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purinergic Signalling and Neurological Diseases: An Update.
    Burnstock G
    CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in purine levels and adenosine receptors in kindled seizures in the rat.
    Adén U; O'Connor WT; Berman RF
    Neuroreport; 2004 Jul; 15(10):1585-9. PubMed ID: 15232288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
    Yu Y; Zhang C
    Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.